investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis

Ulf Klein

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Ulf Klein

Columbia University

New York, United States

Related projects

Satish Gopal

Developing a Clinical Cohort of Histopathologically Characterized Lymphoma

Non-Hodgkin lymphoma Hodgkin lymphoma

Hematology and hematologic malignancies

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Leona W Ayers

Mid-Region Aids and Cancer Specimen Resource Consortium

Non-Hodgkin lymphoma Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Louis Staudt

Molecular Diagnosis and Outcome Prediction in Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Shao-Cong Sun

Oncogenic Activation of Noncanonical NF-kB in B-cell Lymphomas

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

George Thomas

The Function of rpL5 and rpL11 in Induction of p53

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Scott H Kaufmann

Anticancer Drug-Induced BH3-only Protein.Bak Interactions

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Corey Casper

Treatment Outcomes and Survival After a Diagnosis of Endemic Burkitt Lymphoma in Uganda

Non-Hodgkin lymphoma

Hematology and hematologic malignancies